Heparin‐induced thrombocytopenia with thrombosis in COVID‐19 adult respiratory distress syndrome
Open Access
- 20 May 2020
- journal article
- case report
- Published by Elsevier in Research and Practice in Thrombosis and Haemostasis
- Vol. 4 (5) , 936-941
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysisClinica Chimica Acta, 2020
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaNew England Journal of Medicine, 2020
- Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumoniaJournal of Thrombosis and Haemostasis, 2020
- Serotonin‐release assay‐negative heparin‐induced thrombocytopeniaAmerican Journal of Hematology, 2019
- Timeline of heparin‐induced thrombocytopenia seroconversion in serial plasma samples tested using an automated latex immunoturbidimetric assayInternational Journal of Laboratory Hematology, 2019
- American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopeniaBlood Advances, 2018
- Heparin-Induced Thrombocytopenia in the Critically Ill PatientChest, 2018
- Beneficial effect of exogenous platelet factor 4 for detecting pathogenic heparin‐induced thrombocytopenia antibodiesBritish Journal of Haematology, 2017
- Heparin-Induced ThrombocytopeniaNew England Journal of Medicine, 2015
- Nonheparin Anticoagulants for Heparin-Induced ThrombocytopeniaNew England Journal of Medicine, 2013